Hong Kong Training Portal on
Infection Control and Infectious Disease

Epidemiology, Microbiology and Pathogenesis

• Comparative Outcomes of Babesiosis in Immunocompromised and Non-Immunocompromised Hosts: A Multicenter Cohort Study (January 28, 2025)
• Babesiosis and Sickle Red blood Cells: Loss of Deformability, Heightened Osmotic fragility, and Hypervesiculation (January 27, 2025
• Beyond Human Babesiosis: Prevalence and Association of Babesia Coinfection with Mortality in the United States, 2015–2022: A Retrospective Cohort Study (October 2024)
• Transmission risk evaluation of transfusion blood containing low-density Babesia microti (February 5, 2024)
• Reduced Risk of Transfusion-Transmitted Babesiosis With Blood Donor Testing (January 15, 2024)
• Transfusion-transmitted Babesia spp.: a changing landscape of epidemiology, regulation, and risk mitigation (September 26, 2023)
• Surveillance and Risk Analysis for Bovine Babesiosis in England and Wales to Inform Disease Distribution (June 26, 2023)
• Advances in understanding red blood cell modifications by Babesia (September 15, 2022)
• Epidemic status and research progress of babesiosis in China (June 2022)
• Epidemiology of Hospitalized Patients with Babesiosis, United States, 2010-2016 (February 2022)
• Cytochrome b Drug Resistance Mutation Decreases Babesia Fitness in the Tick Stages But Not the Mammalian Erythrocytic Cycle (January 1, 2022)
• Perspectives: Spreading of Human Babesiosis in China: Current Epidemiological Status and Future Challenges (2020)
• Vectors of Babesiosis (October 1, 2018)
• Transfusion‐transmitted and community‐acquired babesiosis in New York, 2004 to 2015 (January 31, 2018).
• Awareness of tick-borne disease and compliance with using tick preventive products of dog owners in Hong Kong (February 1, 2017)
• Screening for Babesia microti in the U.S. Blood Supply (December 8, 2016)
• A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse (June 13, 2016)
• Screening for Babesia microti in the US blood supply (December 8, 2016)
• Babesiosis in China, an emerging threat (February 1, 2015)
• Epidemiological, clinical, and laboratory characteristics of 48 cases of “Babesia venatorum” infection in China: a descriptive study (February 2015)

Case Reports and Case Series

• Autochthonous Human Babesiosis Caused by Babesia venatorum, the Netherlands (September 2024)
• Tafenoquine for Relapsing Babesiosis: A Case Series (July 15, 2024)
• Severe babesiosis due to Babesia divergens acquired in the United Kingdom (January 18, 2021)
• Human Babesiosis Caused by a Babesia crassa-Like Pathogen: A Case Series (October 1, 2018)
• Babesiosis acquired from a pet dog: A second reported case in Hong Kong (August 1, 2016)
• Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review (April 26, 2016)

Clinical Management

• Book Chapter: Babesiosis, Red Book: 2024–2027 Report of the Committee on Infectious Diseases (33nd Edition) (2024)
• Atypical haemolytic uremic syndrome in a patient with severe Babesiosis (June 18, 2024)
• Neurologic Complications of Babesiosis, United States, 2011–2021 (June 2023)
• Cardiac Complications of Human Babesiosis (February 1, 2023)
• A Breathtaking Discovery (February 1, 2023)
• Human Babesiosis (September 2022)
• Recurrence of Human Babesiosis Caused by Reinfection (October 2021)
• Treatment of Human Babesiosis: Then and Now (September 1, 2021)
• Post-Babesiosis Warm Autoimmune Hemolytic Anemia (March 9, 2017)
• Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review (April 26, 2016)
• Neutropenia in Congenital and Adult Babesiosis (July 2015)
• Babesiosis (June 2015)